ADIL

Adial Pharmaceuticals Inc

Jun 15 • 04:00PM ET

2.85

-0.13 -4.36 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: LNAI APRE BCDA BIVI CALC CVM GOVX KAPA KPRX NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-9.90	Insider Own	0.96%	Shs Outstand	2.14M	Perf Week	28.96%
Market Cap	6.11M	Forward P/E	-	EPS next Y	-1.53	Insider Trans	0.00%	Shs Float	2.12M	Perf Month	109.56%
Enterprise Value	1.53M	PEG	-	EPS next Q	-1.02	Inst Own	1.66%	Short Float	2.23%	Perf Quarter	54.05%
Income	-7.77M	P/S	-	EPS this Y	67.76%	Inst Trans	-1.17%	Short Ratio	0.10	Perf Half Y	-61.63%
Sales	0.00M	P/B	1.16	EPS next Y	60.23%	ROA	-179.08%	Short Interest	0.05M	Perf YTD	-48.18%
Book/sh	2.46	P/C	1.33	EPS next 5Y	47.67%	ROE	-265.94%	52W High	18.90 -84.92%	Perf Year	-67.44%
Cash/sh	2.14	P/FCF	-	EPS past 3/5Y	88.55% 53.46%	ROIC	-209.05%	52W Low	1.31 117.56%	Perf 3Y	-98.14%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	38.31% 18.51%	Perf 5Y	-99.83%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	75.60%	Oper. Margin	-	ATR (14)	0.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.18	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	67.46	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.18	EPS Q/Q	82.68%	SMA20	21.20%	Beta	1.38	Target Price	18.67
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	52.44%	Rel Volume	0.54	Prev Close	2.98
Employees	6	LT Debt/Eq	0.00	Earnings	May 11 BMO	SMA200	-44.79%	Avg Volume	452.90K	Price	2.85
IPO	Jul 27, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	45.79% -	Trades		Volume	246,248	Change	-4.36%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)